Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.081
-0.089 (-7.62%)
Mar 31, 2025, 3:51 PM EDT - Market open

Silexion Therapeutics Statistics

Total Valuation

SLXN has a market cap or net worth of $9.09 million. The enterprise value is $7.96 million.

Market Cap 9.09M
Enterprise Value 7.96M

Important Dates

The next estimated earnings date is Wednesday, May 21, 2025, before market open.

Earnings Date May 21, 2025
Ex-Dividend Date n/a

Share Statistics

SLXN has 8.41 million shares outstanding.

Current Share Class 8.41M
Shares Outstanding 8.41M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) 5.91%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.25
P/TBV Ratio 12.57
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.85

Current Ratio 3.85
Quick Ratio 3.64
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -452.67

Financial Efficiency

Return on equity (ROE) is -116.66% and return on invested capital (ROIC) is -73.07%.

Return on Equity (ROE) -116.66%
Return on Assets (ROA) -62.13%
Return on Invested Capital (ROIC) -73.07%
Return on Capital Employed (ROCE) -195.11%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.11
52-Week Price Change n/a
50-Day Moving Average 1.21
200-Day Moving Average n/a
Relative Strength Index (RSI) 45.24
Average Volume (20 Days) 5,213,775

Short Selling Information

The latest short interest is 424,328, so 5.04% of the outstanding shares have been sold short.

Short Interest 424,328
Short Previous Month 976,476
Short % of Shares Out 5.04%
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.36M
Pretax Income n/a
Net Income -1.36M
EBITDA -1.36M
EBIT -1.36M
Earnings Per Share (EPS) -$81.80
Full Income Statement

Balance Sheet

The company has $788,000 in cash and n/a in debt, giving a net cash position of $788,000 or $0.09 per share.

Cash & Cash Equivalents 788,000
Total Debt n/a
Net Cash 788,000
Net Cash Per Share $0.09
Equity (Book Value) 696,000
Book Value Per Share 4.67
Working Capital 687,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$794,000 and capital expenditures -$5,000, giving a free cash flow of -$799,000.

Operating Cash Flow -794,000
Capital Expenditures -5,000
Free Cash Flow -799,000
FCF Per Share -$0.09
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SLXN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -15.49%
FCF Yield -9.13%

Analyst Forecast

The average price target for SLXN is $5.00, which is 362.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.00
Price Target Difference 362.62%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -61.90%
Stock Forecasts

Stock Splits

The last stock split was on November 29, 2024. It was a reverse split with a ratio of 0.1111111:1.

Last Split Date Nov 29, 2024
Split Type Reverse
Split Ratio 0.1111111:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1